Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece

Journal of Clinical Microbiology

Volumn 38, Issue 3, 2000, Pages 1290-1292

  Tsakris, Athanassios ^a   Pournaras, Spyros ^b   Woodford, Neil ^c   Palepou, Marie France I ^c   Babini, Gioia S ^c   Douboyas, John ^b   Livermore, David M ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; EPIDEMIC; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0034088144     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.3.1290-1292.2000     Document Type: Article

References (20)

1. IMP. Antimicrob. Agents Chemother. 39: 1612-1615.
2. Bush, K. 1998. Metallo-β-lactamases: a class apart. Clin. Infect. Dis. 27(Suppl. 1):S48-S53.
3. Cornaglia, G., M. L. Riccio, A. Mazzariol, L. Lauretti, R. Fontana, and G. M. Rossolini. 1999. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 353:899-900.
4. Jacoby, G. A. 1974. Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 6:239-252.
5. Koh, T. H., G. S. Babini, N. Woodford, L. H. Sing, L. M. Hall, and D. M. Livermore. 1999. Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore. Lancet 353:2162.
6. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
7. Legakis, N. J., L. S. Tzouvelekis, A. Tsakris, J. N. Legakis, and A. C. Vatopoulos. 1993. On the incidence of antibiotic resistance among aerobic Gram-negative rods isolated in Greek hospitals. J. Hosp. Infect. 24:233-237.
8. Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
9. Livermore, D. M. 1995. β-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
10. Livermore, D. M., and J. D. Williams. 1996. β-lactams: mode of action and mechanisms of bacterial resistance, p. 502-578. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, Md.
11. Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 1990. Comparison of genomic DNA of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.
12. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Pitt, T. L., D. M. Livermore, G. Miller, A. Vatopoulos, and N. J. Legakis. 1990. Resistance mechanisms of multiresistant serotype O12 Pseudomonas aeruginosa isolated in Europe. J. Antimicrob. Chemother. 26:319-328.
15. Poole, K., K. Krebes, C. McNally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
16. IMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913.
17. Sofianou, D., A. Tsakris, L. Skoura, and J. Douboyas. 1997. Extended high-level cross-resistance to antipseudomonal antibiotics amongst Pseudomonas aeruginosa isolates in a university hospital. J. Antimicrob. Chemother. 40: 740-742.
18. Tassios, P. T., V. Gennimata, A. N. Maniatis, C. Fock, N. J. Legakis, and The Greek Pseudomonas aeruginosa Study Group. 1998. Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. J. Clin. Microbiol. 36:897-901.
19. Tsakris, A., A. C. Vatopoulos, L. S. Tzouvelekis, and N. J. Legakis. 1992. Diversity of resistance phenotypes and plasmid analysis in multi-resistant O:12 Pseudomonas aeruginosa. Eur. J. Epidemiol. 8:865-870.
20. Watanabe, M., S. Iyobe, M. Inoue, and S. Mitsuhashi. 1991. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35:147-151.